Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Effect of TNF-alpha gene polymorphism on outcome of thalidomide-based regimens for multiple myeloma].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 1 Oct 2009

DU Juan, Yuan Zhen-Gang, Zhang Chun-Yang, Fu Wei-Jun, Jiang Hua, Chen Bao-An, Hou Jian

Abstract excerpt

OBJECTIVE: To evaluate the effect of polymorphism at the -238 and -308 position of the TNF-alpha promotor region on the clinical outcome of thalidomide (Thal)-based regimens for the treatment of multiple myeloma (MM). METHODS: The polymorphism at the -238 and -308 position of the TNF-alpha promot...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Multiple Myeloma
Share to Polymorphism, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Thalidomide

Share to Treatment Outcome

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 19954656

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19954656-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Effect of TNF-alpha gene polymorphism on outcome of thalidomide-based regimens for multiple myeloma].PMID 19954656Read ↗

Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.Semantic proximity Read ↗

Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.Semantic proximity Read ↗

Association Of -308G/A, -238G/A TNF-α Polymorphisms with Multiple Myeloma Risk and Survival: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Association between tumor necrosis factor alpha gene polymorphisms and multiple myeloma risk: an updated meta-analysis.Semantic proximity Read ↗

Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients.Semantic proximity Read ↗

Effect of Cytokine Genes in the Pathogenesis and on the Clinical Parameters for the Treatment of Multiple Myeloma.Semantic proximity Read ↗

[Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma].Semantic proximity Read ↗

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple MyelomaSemantic proximity Read ↗

Role of Genetic Polymorphisms -238 G>A and -308 G>A, and Serum TNF-α Levels in a Cohort of Mexican Pediatric Neuroblastoma Patients: Preliminary Study.Semantic proximity Read ↗

[The influence of -238 and -308 TNF alpha polymorphisms on the pathogenesis and response to treatment in rheumatoid arthritis].Semantic proximity Read ↗

[Analysis of the -238(G/A)TNF polymorphism in breast cancer patients].Semantic proximity Read ↗

[The relationship between donor TNFalpha - 308 (G/A) genotype and recipient acute GVHD in allo-BMT].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.